Примери за използване на Effect on the exposure на Английски и техните преводи на Български
{-}
-
Colloquial
-
Official
-
Medicine
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Population pharmacokinetic analysis indicated that hepatitis B and/or C virus co-infection had no clinically relevant effect on the exposure to rilpivirine.
had no clinically relevant effect on the exposure to ledipasvir.
had no clinically relevant effect on the exposure to sofosbuvir and GS-331007.
Population pharmacokinetics analysis in HCV-infected patients indicated that cirrhosis(CPT Class A) had no clinically relevant effect on the exposure to sofosbuvir and GS-331007.
A population pharmacokinetic analysis that compared exposures in smokers versus non-smokers indicated that smoking, which induces CYP1A2, had a minimal effect on the exposure to ADASUVE.
Smokers A population pharmacokinetic analysis that compared exposures in smokers versus non-smokers indicated that smoking, which induces CYP1A2, had a minimal effect on the exposure to ADASUVE.
race had no clinically relevant effect on the exposure of oritavancin.
age did not have a clinically relevant effect on the exposure to sofosbuvir and GS-331007.
age did not have a clinically relevant effect on the exposure to ledipasvir, sofosbuvir or GS-331007.
white blood cell count do not have a clinically important effect on the exposure of total daunorubicin
The effect of administration of more than one weak CYP3A4 inhibitor has not been tested, but the effect on the exposure of lomitapide is expected to be greater than for co-administration of the individual inhibitors with lomitapide.
body weight had no effect on the exposure of abemaciclib in a population pharmacokinetic analysis in patients with cancer(135 males
Medicinal products that are affected by the use of rilpivirine Rilpivirine at a dose of 25 mg once daily is not likely to have a clinically relevant effect on the exposure of medicinal products metabolised by CYP enzymes.
had no clinically significant effect on the exposure of osimertinib(area under the curve(AUC)
and had no effect on the exposure of S-warfarin(the more active enantiomer).
had no relevant effect on the exposure to selexipag but increased the exposure to the active metabolite approximately 2.2
After correcting for the BSA effect, other demographics such as age, body weight and body mass index did not have clinically significant effects on the exposure of imatinib.
no clinically significant effects on the exposure of any of these medicinal products were observed.